However, EGFR-TKIs are cytostatic rather than cytotoxic agents and cannot eradicate micrometastatic tumor cells, even with highly significant clinical efficacy ( 30 ).
← all excerpts
Strategies and influencing factors for the treatment of advanced non-small cell lung cancer based on epidermal growth factor receptor tyrosine kinase inhibitors: a narrative review.
1
—
—